LINDAHL RICHARD S 4
4 · Emergent BioSolutions Inc. · Filed Mar 5, 2026
Insider Transaction Report
Form 4
LINDAHL RICHARD S
EVP, Chief Financial Officer
Transactions
- Tax Payment
Common Stock
[F1]2026-03-05$8.44/sh−23,650$199,606→ 215,367 total - Award
Employee Stock Option (Right to buy)
[F2]2026-03-03+72,856→ 557,346 totalExercise: $8.99Exp: 2033-03-02→ Common Stock (72,856 underlying)
Footnotes (2)
- [F1]Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units
- [F2]Vests in three equal installments beginning on the day prior to the anniversary date of the grant.
Signature
/s/ Richard S. Lindahl|2026-03-05